Skip to main content
Clinical Trials/NCT00755924
NCT00755924
Completed
Phase 1

Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

HealthPartners Institute1 site in 1 country114 target enrollmentJune 2008

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cholesterol, HDL
Sponsor
HealthPartners Institute
Enrollment
114
Locations
1
Primary Endpoint
Change in HDL-Cholesterol level
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.

Registry
clinicaltrials.gov
Start Date
June 2008
End Date
July 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Those older than 18 years of age
  • Park Nicollet Health Services patient

Exclusion Criteria

  • Because of a potential positive effect of vinegar on improving diabetes mellitus8 and the subsequent change in medication regime for diabetes diabetic patients will be excluded from this study. If this study finds that vinegar does increase HDL levels, a subsequent study of diabetic patients will be conducted.
  • History of allergy to apple cider vinegar
  • Those with a terminal illness
  • Diagnosis of Inflammatory bowel disease
  • Those with Immunosuppression diseases
  • Patients on dialysis
  • Severe psychiatric illness who are unable to consent or reliably participate
  • No evidence of end stage renal disease
  • Those who use alcohol greater than or equal to 2 drinks per day
  • Those who take in \>3 tsp vinegar/day supplement

Outcomes

Primary Outcomes

Change in HDL-Cholesterol level

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials